EUVIMEDOpdag EUVIMED
Netzwerk-MetaanalyseOpen access

Multi‐state network meta‐analysis of progression and survival data

Jeroen P Jansen iD, Devin Incerti, Thomas A Trikalinos

Statistics in Medicine · 2023-08-30 · 42 (19) · 3371-3391

DOI: 10.1002/sim.9810 ↗

At a glance

Netzwerk-Metaanalyse in Statistics in Medicine, published online on 2023-06-10. Written by Jeroen P Jansen and 2 co-authors. Institution: Center for Translational and Policy Research on Precision Medicine, Department of Clinical Pharmacy, School of Pharmacy, Helen Diller Family Comprehe…. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Cited 13 times so far (Crossref); 40 references. The full text is freely available in PubMed Central. Funded by: NHGRI NIH HHS, NCI NIH HHS, National Cancer Institute.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Multiple randomized controlled trials, each comparing a subset of competing interventions, can be synthesized by means of a network meta‐analysis to estimate relative treatment effects between all interventions in the evidence base. Here we focus on estimating relative treatment effects for time‐to‐event outcomes. Cancer treatment effectiveness is frequently quantified by analyzing overall survival (OS) and progression‐free survival (PFS). We introduce a method for the joint network meta‐analysis of PFS and OS that is based on a time‐inhomogeneous tri‐state (stable, progression, and death) Markov model where time‐varying transition rates and relative treatment effects are modeled with parametric survival functions or fractional polynomials. The data needed to run these analyses can be extracted directly from published survival curves. We demonstrate use by applying the methodology to a network of trials for the treatment of non‐small‐cell lung cancer. The proposed approach allows the joint synthesis of OS and PFS, relaxes the proportional hazards assumption, extends to a network of more than two treatments, and simplifies the parameterization of decision and cost‐effectiveness analyses.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansTreatment OutcomeProgression-Free SurvivalDisease-Free Survival

Author keywords

aggregate level datamulti-state modelsnetwork meta-analysisnon-proportional hazardstime-to-event data

Authors and institutions

  • Center for Translational and Policy Research on Precision Medicine, Department of Clinical Pharmacy, School of Pharmacy, Helen Diller Family Comprehensive Cancer Center, Institute for Health Policy Studies, University o…
  • PRECISIONheor, San Francisco, California, USA.
  • Previously at PRECISIONheor, San Francisco, California, USA.
  • Departments of Health Services, Policy and Practice and of Biostatistics and Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, Rhode Island, USA.

ORCID profiles: Jeroen P Jansen

Funding

  • NHGRI NIH HHS
  • NCI NIH HHS
  • National Cancer Institute

Cite

APA

Jansen, J. P., Incerti, D., & Trikalinos, T. A. (2023). Multi‐state network meta‐analysis of progression and survival data. Statistics in Medicine, 42(19), 3371-3391. https://doi.org/10.1002/sim.9810

Vancouver

Jansen JP, Incerti D, Trikalinos TA. Multi‐state network meta‐analysis of progression and survival data. Statistics in Medicine. 2023;42(19):3371-3391. doi:10.1002/sim.9810

BibTeX
@article{Jansen2023,
  author = {Jansen, Jeroen P and Incerti, Devin and Trikalinos, Thomas A},
  title = {Multi‐state network meta‐analysis of progression and survival data},
  journal = {Statistics in Medicine},
  year = {2023},
  volume = {42},
  number = {19},
  pages = {3371--3391},
  doi = {10.1002/sim.9810}
}
Start for free →